BOM:539470 has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
BOM:539470 has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Shree Ganesh Biotech (India) Ltd BOM:539470
Shree Ganesh Biotech (India) BOM:539470 45 Median PS Value is ₹0.00 as of Jul. 12, 2026. GuruFocus rates BOM:539470 with a GF Score™ of 45/100 and a GF Value™ of ₹0.20 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 140 Agriculture companies, Shree Ganesh Biotech (India) ranks worse than 714285% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Shree Ganesh Biotech (India)'s Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.136. Shree Ganesh Biotech (India)'s 10-Year median PS Ratio is 0. Therefore, the Median PS Value for today is ₹0.00.
As of today (2026-07-12), Shree Ganesh Biotech (India)'s share price is ₹0.54. Shree Ganesh Biotech (India)'s Median PS Value is ₹0.00. Therefore, Shree Ganesh Biotech (India)'s Price to Median PS Value for today is 0.00.
The historical rank and industry rank for Shree Ganesh Biotech (India)'s Median PS Value or its related term are showing as below:
Shree Ganesh Biotech (India) (BOM:539470) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Shree Ganesh Biotech (India)'s Price to Median PS Value for today is calculated as
| Price to Median PS Value | = | Share Price | / | Median PS Value |
| = | 0.54 | / | 0.00 | |
| = |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The historical data trend for Shree Ganesh Biotech (India)'s Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
| Shree Ganesh Biotech (India) Annual Data | |||||||||||||||||||||
| Trend | Mar17 | Mar18 | Mar19 | Mar20 | Mar21 | Mar22 | Mar23 | Mar24 | Mar25 | Mar26 | |||||||||||
| Median PS Value | Get a 7-Day Free Trial |
|
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||
| Shree Ganesh Biotech (India) Quarterly Data | ||||||||||||||||||||
| Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | Mar25 | Jun25 | Sep25 | Dec25 | Mar26 | |
| Median PS Value | Get a 7-Day Free Trial |
|
|
|
|
|
|
|
|
|
|
|
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
For the Agricultural Inputs subindustry, Shree Ganesh Biotech (India)'s Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Agriculture industry and Basic Materials sector, Shree Ganesh Biotech (India)'s Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Shree Ganesh Biotech (India)'s Price-to-Median-PS-Value falls into.
Shree Ganesh Biotech (India)'s Median PS Value for today is calculated as
| Median PS Value | = | Revenue per Share (TTM) | * | 10-Year Median PS Ratio |
| = | 0.136 | * | 0 | |
| = | 0.00 |
10-Year Median PS Ratio is 0.
Shree Ganesh Biotech (India)'s Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.136.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Based on GuruFocus' analysis, Shree Ganesh Biotech (India) stock appears to be overvalued. The current stock price of ₹0.54 is trading 170% above its estimated GF Value™ of ₹0.20. GuruFocus considers Shree Ganesh Biotech (India) to be Significantly Overvalued.
Key valuation signals for BOM:539470:
No single metric tells the full story. See the BOM:539470 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.